The TNBC MERIT trial is going on…

on 03/01/2018 Allgemein with 0 comments

We are happy to continue the TNBC MERIT clinical trial in triple negative breast cancer in 2018 and looking forward to treat the first patient with the fully individualized cancer vaccine soon.